Leishmaniasis in HIV infection

J Postgrad Med. 2003 Jan-Mar;49(1):39-49. doi: 10.4103/0022-3859.929.

Abstract

Herein we review the particular aspects of leishmaniasis associated with HIV infection. The data in this review are mainly from papers identified from PubMed searches and from papers in reference lists of reviewed articles and from the authors' personal archives. Epidemiological data of HIV/Leishmania co-infection is discussed, with special focus on the influence of Highly Active Antiretroviral Therapy (HAART) on incidence of leishmaniasis and transmission modalities. Microbiological characteristics, pathogenesis, clinical presentation and specific treatment of the co-infection are also presented.

Publication types

  • Review

MeSH terms

  • AIDS-Related Opportunistic Infections / diagnosis*
  • AIDS-Related Opportunistic Infections / drug therapy
  • AIDS-Related Opportunistic Infections / epidemiology
  • AIDS-Related Opportunistic Infections / parasitology*
  • Animals
  • Antimony / therapeutic use
  • Antiprotozoal Agents / therapeutic use
  • Antiretroviral Therapy, Highly Active
  • HIV / pathogenicity
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • Humans
  • Leishmania / pathogenicity
  • Leishmaniasis / complications*
  • Leishmaniasis / diagnosis*
  • Leishmaniasis / drug therapy
  • Leishmaniasis / epidemiology
  • Risk Factors

Substances

  • Antiprotozoal Agents
  • Antimony